For pediatric neurology patients, there are marked ethnoracial disparities in genetic testing completion, according to a study.

Any patient suffering from new or worsening medical symptoms hopes for a relatively quick and accurate diagnosis.

Love-Preet Kalra, M.D., from RKH Hospital Klinikum Ludwigsburg in Germany, and colleagues examined the potential of a new GFAP point-of-care test for ... moderate-to-severe neurological deficit.

From quaternary hospitals nationally recognized for their care, to convenient doctors’ offices within the community, the Institute for Neurology and Neurosurgery is able to provide exceptional, ...

Brain derived neurotrophic factor (a secreted protein) is acknowledged for its role in promoting neurogenesis and, consequently, also facilitating neurological plasticity (Ding, Ying ...

both the patient's blood and the GFAP test must be available as a “point of care” test in the field,” McCullough, chief of neurology at Memorial Hermann Hospital-Texas Medical Center in Houston, said ...

However, especially in the realm of neurological and psychiatric disorders, traditional drug development methods are failing us. Animal models, particularly mice, very often fail to predict human ...

Check doctor says on this syndrome. Trending Photos Pune has reported six new suspected cases of Guillain-Barré Syndrome (GBS), a rare neurological disorder, bringing the total number of cases in the ...